6-O-sulfated heparan sulfate epitope (6-O-S HS) (6-O-S HS)

The 6-O-sulfated heparan sulfate epitope is a specific structural motif within heparan sulfate (HS) glycosaminoglycan chains, characterized by the presence of sulfate groups at the C-6 position of glucosamine residues [1, 2]. This epitope serves as a critical docking site for numerous signaling proteins, including fibroblast growth factors (FGFs), vascular endothelial growth factors (VEGFs), and Wnt proteins, thereby modulating essential cellular processes such as proliferation, migration, and differentiation [3, 4]. In the context of oncology, 6-O-sulfation is frequently upregulated in the tumor microenvironment, where it facilitates pathological angiogenesis and tumor invasion by enhancing growth factor bioavailability [5]. Therapeutic strategies targeting this epitope include the use of heparan sulfate mimetics like pixatimod (PG545) and muparfostat (PI-88), which are designed to disrupt the interaction between HS and its pro-tumorigenic ligands [6]. Additionally, enzymes like SULF1 and SULF2, which specifically remove 6-O-sulfate groups, act as endogenous regulators of this epitope's bioactivity and are themselves targets for drug development [7].

Other names

6-O-sulfated heparan sulfate6-O-sulfated glucosamine heparan sulfateHS 6-O-sulfate epitope6S-HSHighly 6-O-sulfated heparan sulfate domains

Competitive inhibition of ligand binding to heparan sulfate chains, preventing the formation of ternary signaling complexes (e.g., FGF-HS-FGFR) and inhibiting heparanase-mediated remodeling of the extracellular matrix.